Tingyan Shi Selected Research

Tingyan Shi Research Topics

12	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 10/2015
10	Neoplasms (Cancer) 03/2024 - 10/2015
6	Ovarian Epithelial Carcinoma 01/2021 - 10/2015
2	Disease Progression 01/2021 - 01/2020
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2017 - 01/2015
2	Rectal Neoplasms (Rectal Cancer) 11/2015 - 01/2015
1	Hyperthermia 03/2024
1	Neutropenia 01/2021
1	Ascites 01/2021
1	Photosensitivity Disorders (Photodermatitis) 01/2021
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 09/2020
1	Carcinoma (Carcinomatosis) 09/2020
1	Fallopian Tube Neoplasms 09/2020
1	Endometrial Neoplasms (Endometrial Cancer) 03/2019
1	Genomic Instability 01/2017
1	Carcinogenesis 10/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2015
1	Diarrhea 01/2015
1	Prostatic Neoplasms (Prostate Cancer) 05/2013

5	PlatinumIBA 01/2022 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2015
2	niraparibIBA 01/2022 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 01/2015
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 03/2024
1	Drug CombinationsIBA 03/2024
1	Cleavage And Polyadenylation Specificity FactorIBA 11/2023
1	BoronIBA 11/2023
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2023
1	MicrogelsIBA 06/2023
1	Oxygen (Dioxygen)IBA 06/2023
1	Photosensitizing Agents (Photosensitizers)IBA 06/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2023
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Zn(II)-phthalocyanine (zinc phthalocyanine)IBA 01/2021
1	cyanogenIBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	AntigensIBA 01/2021
1	SulfadimethoxineIBA 01/2021
1	RacivirIBA 09/2020
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	exodeoxyribonuclease IIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 11/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2015
1	Interleukin-1 (Interleukin 1)IBA 11/2015
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 10/2015
1	ParaffinIBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Myeloid Cell Leukemia Sequence 1 ProteinIBA 01/2015
1	Plasminogen Activator Inhibitor 1IBA 01/2015
1	Apoptosis Regulatory ProteinsIBA 01/2015
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2015
1	AndrogensIBA 05/2013
1	3-Oxo-5-alpha-Steroid 4-Dehydrogenase (Testosterone 5 alpha Reductase)IBA 05/2013
1	SteroidsIBA 05/2013

7	Therapeutics 03/2024 - 10/2015
6	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
2	Cytoreduction Surgical Procedures 01/2022 - 01/2020
2	Immunotherapy 01/2021 - 03/2019
2	Neoadjuvant Therapy 09/2020 - 10/2015
2	Radiotherapy 03/2019 - 01/2015
1	Induced Hyperthermia (Thermotherapy) 03/2024
1	Hyperthermic Intraperitoneal Chemotherapy 03/2024
1	Photochemotherapy (Photodynamic Therapy) 06/2023
1	Intravenous Administration 06/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021
1	Operative Time 10/2017
1	Hysterectomy 10/2017
1	Catheters 10/2017
1	Chemoradiotherapy 11/2015